RESULTS

That Deliver Confidence

PUBLICATIONS & ABSTRACTS

Respicardia is committed to the continued publication of clinical data supporting the benefit of transvenous phrenic nerve stimulation for the treatment of central sleep apnea.

Who is the remedē® System for?

Learn how to identify patients at risk for CSA and how the condition is diagnosed.

Am I a candidate
for remedē®?